Clinical Trial Update: Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ARYS-01 cream 3% (sorivudine), oral valaciclovir, and their combination for treatment of herpes zoster and prevention of postherpetic n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Postherpetic Neuralgia

Drugs mentioned

• ARYS-01 cream 3% (sorivudine)
• Valaciclovir (valaciclovir)

Snippet

Sponsor: aRigen Pharmaceuticals, Inc. | Conditions: Herpes Zoster, Postherpetic Neuralgia | Phase 2 | Status: UNKNOWN